default author photo

Nadia Saoudi Gonzalez

Vall d’Hebron Institute of Oncology (VHIO)

SCHOLARLY PAPERS

2

DOWNLOADS

143

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Association between sex and response to encorafenib-based combinations in BRAF V600E mutant metastatic colorectal cancer

Downloads 100 (730,864)

Association between sex and response to encorafenib-based combinations in BRAF V600E mutant metastatic colorectal cancer

Number of pages: 30 Posted: 31 Aug 2025
Javier Ros, Víctor Navarro, Guillermo Villacampa, Raquel Comas Navarro, Alessandra Boccaccino, Iosune Baraibar, Vincenzo Nasca, Nadia Saoudi Gonzalez, Francesc Salvà, Marta Rodriguez, Adriana Alcaraz, Ariadna Garcia Rodriguez, Javier Carmona and Marco Maria Germani
affiliation not provided to SSRN, Vall d'Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Pisa - Department of Translational Research and of New Surgical and Medical Technologies, affiliation not provided to SSRN, Fondazione IRCCS Istituto Nazionale dei Tumori, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Ospedale Santa Chiara - Azienda Ospedaliero Universitaria Pisana
Downloads 70 (929,821)

Abstract:

Loading...

BRAF mutation, Colorectal cancer, Biomarker, Sex, MEK inhibitor, binimetinib

Association between sex and response to encorafenib-based combinations in BRAF V600E mutant metastatic colorectal cancer

Number of pages: 52 Posted: 24 Nov 2025
Javier Ros, Víctor Navarro, Guillermo Villacampa, Raquel Comas Navarro, Alessandra Boccaccino, Iosune Baraibar, Vincenzo Nasca, Nadia Saoudi Gonzalez, Francesc Salvà, Marta Rodriguez, Adriana Alcaraz, Ariadna Garcia Rodriguez, Javier Carmona, Marco Maria Germani, Francesca Bergamo, Lisa Salvatore, Beatrice Borelli, Alessandro Passardi, Lorenzo Antonuzzo, Guglielmo Vetere, Stefano Tamberi, Sara Lonardi, Filippo Pietrantonio, Chiara Cremolini, Josep Tabernero, Josep Tabernero and Maria Elena Elez
affiliation not provided to SSRN, Vall d'Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Pisa - Department of Translational Research and of New Surgical and Medical Technologies, affiliation not provided to SSRN, Fondazione IRCCS Istituto Nazionale dei Tumori, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ospedale Santa Chiara - Azienda Ospedaliero Universitaria Pisana, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Medical Oncology 1, Fondazione Policlinico Universitario A. Gemelli IRCCS - Oncologia Medica, University Hospital of Pisa - Unit of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - Department of Medical Oncology, Careggi University Hospital of Florence - Clinical Oncology Unit, Ospedale Santa Chiara - Azienda Ospedaliero Universitaria Pisana, AUSL Romagna - Oncology Unit, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Medical Oncology, University Hospital of Pisa - Unit of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron and Vall d’Hebron Institute of Oncology (VHIO)
Downloads 30 (1,400,723)

Abstract:

Loading...

BRAF mutation, colorectal cancer, Biomarker, sex, MEK inhibitor, binimetinib

2.

A Pan-Cancer Clinical Platform to Predict Immunotherapy Outcomes and Prioritize Immuno-Oncology Combinations in Early-Phase Trials

Number of pages: 34 Posted: 17 Feb 2023
Alberto Hernando, Maria Vila-Casadesús, Yacine Bareche, Alberto Gonzalez-Medina, Francesco Mancuso, Deborah Lo Giacco, Agatha Martin, Omar Saavedra, Irene Brana, Maria Vieito, Roberta Fasani, John Stagg, Farnoosh Abbas-Aghababazadeh, Benjamin Haibe-Kains, Roger Berche, Nadia Saoudi Gonzalez, Claudia Valverde, Eva Muñoz-Couselo, Cristina Suarez, Marc Diez, Maria Elena Elez, Jaume Capdevila, Ana Oaknin, Cristina Saura, Teresa Macarulla, Joan Carles Galceran, Enriqueta Felip, Rodrigo Dienstmann, Philippe L. Bedard, Paolo Nuciforo, Joan Seoane, Josep Tabernero, Josep Tabernero, Elena Garralda and Ana Vivancos
Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), University of Montreal - Faculté de Pharmacie, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Université de Montréal - Faculty of Pharmacy, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)
Downloads 43 (1,145,425)

Abstract:

Loading...